Status:
RECRUITING
Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Microsporidiosis Intestinal
Heart Transplant Infection
Eligibility:
All Genders
Brief Summary
The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.
Detailed Description
Microsporidia constitute a large family of intracellular eukaryotes infecting a wide range of hosts, ranging from insects to mammals and birds. Within this group, some species are responsible for inte...
Eligibility Criteria
Inclusion
- heart transplant patients diagnosed with intestinal microsporidiosis
- diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories)
Exclusion
- patient opposition
Key Trial Info
Start Date :
May 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06986980
Start Date
May 5 2025
End Date
December 1 2025
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Gabriel Montpied
Clermont-Ferrand, France, 63000